Oncorena is aiming to save human lives by transforming a natural substance into a breakthrough therapy treatment for advanced kidney cancer. We have completed all preclinical studies and are moving into early-stage clinical development. The objective is to confirm the powerful anti-tumor activity of our drug candidate - based on the natural substance orellanine - in advanced kidney cancer patients. Oncorena AB is headquartered in Lund, Sweden.
View Top Employees from Oncorena ABWebsite | http://www.oncorena.com |
Revenue | $811000 |
Employees | 11 (2 on RocketReach) |
Founded | 2011 |
Address | 1 Medicon Village Scheeletorget, Lund, Skane 223 81, SE |
Phone | +46 70 664 94 77 |
Technologies |
JavaScript,
HTML,
PHP
+6 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Health Care, Pharmaceuticals, Therapeutics, Healthcare |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Oncorena AB employee's phone or email?
The Oncorena AB annual revenue was $811000 in 2024.
2 people are employed at Oncorena AB.
Oncorena AB is based in Lund, Skane.
The NAICS codes for Oncorena AB are [325, 3254, 32, 32541].
The SIC codes for Oncorena AB are [283, 28].